These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10125703)

  • 21. Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
    Kale SA; Barkin RL
    Compr Ther; 2009; 35(2):68-71. PubMed ID: 19618754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. For pharmaceutical companies, a data warehouse can be just what the doctor ordered.
    Desai A
    Health Manag Technol; 1999 Mar; 20(2):20-2. PubMed ID: 10346471
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug information residency rotation with pharmaceutical industry.
    Cramer RL
    Am J Pharm Educ; 1986; 50(2):154-6. PubMed ID: 10277398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug information services at Pfizer labs.
    Gasperino JL
    Am J Hosp Pharm; 1990 Sep; 47(9):1998-9. PubMed ID: 2220851
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug information services at the Upjohn Company.
    Baker RP; Gurwich EL; Depew CC
    Am J Hosp Pharm; 1990 Sep; 47(9):1999-2001. PubMed ID: 2220852
    [No Abstract]   [Full Text] [Related]  

  • 26. [One year's written drug information to a general practitioner].
    Molaug PO; Spigset O
    Tidsskr Nor Laegeforen; 2001 Feb; 121(5):585-8. PubMed ID: 11301615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
    Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1997 annual market directory issue.
    Health Manag Technol; 1997 Feb; 18(3):8-130. PubMed ID: 10165196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redistribution of risk throughout the pharmaceutical industry.
    Scheur BS
    Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of pharmaceutical manufacturers as a source of drug information to a telephone inquiry: generic vs brand.
    Generali JA; Hogan L
    Drug Inf J; 1983; 17(3):195-204. PubMed ID: 10265096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical manufacturers listing: 1989 update.
    Clifford JH; Miwa LJ
    J Pharm Technol; 1989; 5(1):27-37. PubMed ID: 10304342
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug information resources for treatment of acute drug overdose.
    Comstock EG
    Drug Inf J; 1975; 9(2-3):81-8. PubMed ID: 10236983
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmaceutical manufacturers ... leaving tradition behind and forging new managed care alliances.
    Barnett AA
    State Health Care Am; 1995; ():41-6. PubMed ID: 10168072
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmaceutical manufacturers listing: 1990 update.
    Massoummi F; Haley CJ
    J Pharm Technol; 1990; 6(4):151-65. PubMed ID: 10106926
    [No Abstract]   [Full Text] [Related]  

  • 37. Is drug advertising informing the consumer?
    Hanlon PM
    Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141
    [No Abstract]   [Full Text] [Related]  

  • 38. Mary Carter agreements and disclosure by drug manufacturers.
    Pickens A
    Tex Med; 1978 Oct; 74(10):27-8. PubMed ID: 715732
    [No Abstract]   [Full Text] [Related]  

  • 39. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Discouraging about drug therapy?].
    Reseland S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1910-1. PubMed ID: 12830286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.